Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Federal Trade Commission
Fuji
Covington
McKesson
Chinese Patent Office
Cantor Fitzgerald
Healthtrust
Farmers Insurance
Boehringer Ingelheim

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,157,466

« Back to Dashboard

Which drugs does patent 7,157,466 protect, and when does it expire?

Patent 7,157,466 protects TYKERB and is included in one NDA.

This patent has forty-four patent family members in twenty-six countries.
Summary for Patent: 7,157,466
Title:Quinazoline ditosylate salt compounds
Abstract:Ditosylate salts of 4-quinazolineamines are described as well as methods of using the same in the treatment of disorde4rs characterized by aberrant erbB family PTK activity.
Inventor(s): McClure; Michael Scott (Durham, NC), Osterhout; Martin Howard (Durham, NC), Roschangar; Frank (Glen Allen, VA), Sacchetti; Mark Joseph (Foster City, CA)
Assignee: SmithKline Beecham (Cork) Limited (IE)
Application Number:10/311,678
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 7,157,466

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Novartis Pharms Corp TYKERB lapatinib ditosylate TABLET;ORAL 022059-001 Mar 13, 2007 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,157,466

PCT Information
PCT FiledJune 28, 2001PCT Application Number:PCT/US01/20706
PCT Publication Date:January 10, 2002PCT Publication Number: WO02/02552

International Patents Family Members for US Patent 7,157,466

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1440403 ➤ Try a Free Trial
China 1211382 ➤ Try a Free Trial
China 1636992 ➤ Try a Free Trial
China 1305872 ➤ Try a Free Trial
Cyprus 1107054 ➤ Try a Free Trial
Czech Republic 20024223 ➤ Try a Free Trial
Denmark 1294715 ➤ Try a Free Trial
Czech Republic 299561 ➤ Try a Free Trial
European Patent Office 1294715 ➤ Try a Free Trial
Czech Republic 300945 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Covington
Boehringer Ingelheim
US Army
Cerilliant
Colorcon
McKesson
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot